Revenue by Business Type
(Unit: Million Baht, %) Cord Blood
Cord Tissue
Adipose Tissue
NK Cells
Hair Folicle
Others
| Balance Sheet as of | 2022 31/12/2022 |
2023 31/12/2023 |
2024 31/12/2024 |
9M2025 30/09/2025 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 781,757,623 | 1,019,208,161 | 3,429,038,729 | 3,507,603,278 |
| Cash and Cash Equivalents | 447,449,808 | 183,341,213 | 838,196,958 | 957,819,702 |
| Inventory | 15,171,513 | 12,153,006 | 18,004,686 | 35,964,974 |
| Other Current Assets | 21,208,313 | 17,823,118 | 29,488,977 | 29,489,181 |
| Property, Plant, and Equipment | 167,485,468 | 184,662,403 | 299,590,083 | 363,271,981 |
| Other Non-Current Assets | 676,704 | 957,370 | 1,274,372 | 1,260,296 |
| Liabilities | 352,069,548 | 444,220,758 | 506,183,103 | 529,239,189 |
| Current Liabilities | 89,521,511 | 137,795,104 | 124,658,937 | 112,790,026 |
| Lease Liabilities Due Within One Year | 5,684,235 | 5,118,996 | 7,152,111 | 7,923,117 |
| Non-Current Liabilities | 262,548,037 | 306,425,654 | 381,524,166 | 416,449,163 |
| Total Equity | 429,688,075 | 574,987,403 | 3,429,038,729 | 3,507,603,278 |
| Share Capital | ||||
| Registered Capital | 300,000,000 | 400,000,000 | 534,000,000 | 534,000,000 |
| Issued Capital Fully Paid | 225,000,000 | 400,000,000 | 534,000,000 | 534,000,000 |
| Income Statement as of | 2022 31/12/2022 |
2023 31/12/2023 |
2024 31/12/2024 |
9M2025 30/09/2025 |
|---|---|---|---|---|
| Service Revenue | 591,820,470 | 694,260,507 | 824,143,130 | 565,325,631 |
| Operating Profit | 191,039,629 | 304,360,207 | 364,194,418 | 176,450,034 |
| Profit for the Year/Period | 147,187,508 | 239,565,813 | 338,738,952 | 159,948,370 |
Notes
- The Stock Exchange displays the latest financial statement information as submitted by listed companies. This information depends on the company's fiscal year-end date, where some companies may have a fiscal year-end date other than December 31 (31/12), or some companies may report for periods other than 12 months. Users should refer to the full financial statements for additional details.
- The financial statement information reflects data submitted by listed companies for each respective period. Users should consult the full financial statements for additional details, as some companies may have adjusted comparative figures in their latest full financial statements.
- For foreign listed companies (Secondary Listing), the statistical ratios P/E, P/BV, and Dividend Yield are calculated using the Bank of Thailand's exchange rates for comparative estimation purposes only.
- For foreign listed companies (Secondary Listing), financial statement information complies with the regulations of their Home Exchange.